Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0015672 (fatigue)
 51,768 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Specific clinical problems emerge in middle-aged men, not so much because of aging, but as a result of the path they have chosen to follow and their reaction to life experiences. For instance, the middle-aged executive has probably spent a lifetime working towards success. His daily existence is characterized by aggression, and his drive to conquer may make him prone to heart disease. Mild depression due to anxious self scrutiny also is common in middle age. Depression and fatigue may lead some patients to overindulge in food, alcohol and/or drugs. Others may become addicted to exercise. These patients look on pain as an ominous threat to their finely balanced daily ritual, and therefore may disregard the warning signs of injury or illness. In treating the problems of middle age, physicians should remember that most middle-aged patients have acquired some practical wisdom.
 ...
PMID:The 'age of never'. 2127 95

Depression is a major neuropsychiatric disorder common in patients with rheumatological conditions including spondyloarthritis (SpA). It is associated with higher disease activity, functional impairment, poor treatment response and quality of life in patients with musculoskeletal disorders. Using ankylosing spondylitis (AS) and psoriatic arthritis (PsA) as examples, we have reviewed the evidence regarding the burden, risk factors, potential mechanisms and clinical management of depression in spondyloarthritis. The prevalence of depression is higher in patients with AS and PsA compared with the general population, with evidence of moderate/severe depression in about 15% of patients with AS or PsA. Mild depression is even more common and estimated to be present in about 40% of patients with AS. In addition to conventional risk factors such as stressful life events and socioeconomic deprivation, increased risk of depression in SpA may be associated with disease-related factors, such as disease activity, poor quality of life, fatigue, and sleep disturbances. Emerging evidence implicates inflammation in the aetiology of depression, which could also be a shared mechanism for depression and chronic inflammatory conditions such as AS and PsA. It is imperative for clinicians to actively assess and treat depression in SpA, as this could improve treatment adherence, quality of life, and overall long-term clinical and occupational outcomes. The use of validated tools can aid recognition and management of depression in rheumatology clinics. Management of depression in SpA, especially when to refer to specialist mental health services, are discussed.
 ...
PMID:Depression in patients with spondyloarthritis: prevalence, incidence, risk factors, mechanisms and management. 3322 81